$ACON
Aclarion, Inc. Stock $acon

$acon Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000168316822007614 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3
Revenue	$22.52K	$18.22K
YoY Change		67.71%
Cost Of Revenue	$17.29K	$17.03K
YoY Change		5.86%
Gross Profit	$5.230K	$1.194K
YoY Change		-122.87%
Gross Profit Margin	23.22%	6.55%
Selling, General & Admin	$1.092M	$1.343M
YoY Change		159.99%
% of Gross Profit	20883.37%	112519.93%
Research & Development	$239.8K	$291.0K
YoY Change		5.7%
% of Gross Profit	4584.7%	24369.01%
Depreciation & Amortization	$51.77K	$47.14K
YoY Change
% of Gross Profit	989.87%	3948.07%
Operating Expenses	$1.332M	$1.634M
YoY Change		106.36%
Operating Profit	-$1.327M	-$1.633M
YoY Change		104.86%
Interest Expense	-$2.070K	$2.070K
YoY Change		-98.77%
% of Operating Profit
Other Income/Expense, Net	-$80.00	$227.00
YoY Change		-100.01%
Pretax Income	-$1.329M	-$1.633M
YoY Change
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$1.329M	-$1.633M
YoY Change		-44.69%
Net Earnings / Revenue	-5901.02%	-8961.88%
Basic Earnings Per Share		-$0.21
Diluted Earnings Per Share	-$0.17	-$0.21
COMMON SHARES
Basic Shares Outstanding	7.822M shares	7.822M shares
Diluted Shares Outstanding		7.822M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.473M	$2.656M
YoY Change
Cash & Equivalents	$1.473M	$2.666M	$452.5K
Short-Term Investments
Other Short-Term Assets	$496.9K	$198.3K
YoY Change
Inventory
Prepaid Expenses
Receivables	$18.57K	$25.50K	$6.280K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.988M	$2.880M	$732.2K
YoY Change	171.54%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.346K	$4.035K	$12.64K
YoY Change	-73.52%
Goodwill
YoY Change
Intangibles	$1.214M	$1.217M	$1.145M
YoY Change	6.09%
Long-Term Investments
YoY Change
Other Assets	$0.00
YoY Change
Total Long-Term Assets	$1.218M	$1.221M	$1.157M
YoY Change	5.22%
TOTAL ASSETS
Total Short-Term Assets	$1.988M	$2.880M	$732.2K
Total Long-Term Assets	$1.218M	$1.221M	$1.157M
Total Assets	$3.206M	$4.101M	$1.889M
YoY Change	69.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$462.2K	$718.3K	$1.065M
YoY Change	-56.61%
Accrued Expenses	$610.8K	$450.2K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.418M	$1.168M	$7.619M
YoY Change	-81.39%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.418M	$1.168M	$7.619M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$1.418M	$1.168M	$7.619M
YoY Change	-81.39%
SHAREHOLDERS EQUITY
Retained Earnings	-$39.91M	-$38.58M	-$31.89M
YoY Change	25.16%
Common Stock	$79.00	$78.00	$9.00
YoY Change	777.78%
Preferred Stock	$0.00	$0.00	$7.102M
YoY Change	-100.0%
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.788M	$2.933M	-$5.729M
YoY Change
Total Liabilities & Shareholders Equity	$3.206M	$4.101M	$1.889M
YoY Change	69.68%

Cashflow Statement

Concept	2022 Q4	2022 Q3
OPERATING ACTIVITIES
Net Income	-$1.329M	-$1.633M
YoY Change		-44.69%
Depreciation, Depletion And Amortization	$51.77K	$47.14K
YoY Change
Cash From Operating Activities	-$1.135M	-$1.098M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures	$48.25K	-$38.66K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$48.25K	-$38.66K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000
YoY Change
NET CHANGE
Cash From Operating Activities	-1.135M	-1.098M
Cash From Investing Activities	-48.25K	-38.66K
Cash From Financing Activities	0.000	0.000
Net Change In Cash	-1.183M	-1.137M
YoY Change
FREE CASH FLOW
Cash From Operating Activities	-$1.135M	-$1.098M
Capital Expenditures	$48.25K	-$38.66K
Free Cash Flow	-$1.183M	-$1.059M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Entity Central Index Key EntityCentralIndexKey	0001635077
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41358
	dei	Entity Registrant Name EntityRegistrantName	ACLARION, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3324725
	dei	Entity Address Address Line1 EntityAddressAddressLine1	8181 Arista Place
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100
	dei	Entity Address City Or Town EntityAddressCityOrTown	Broomfield
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80021
	dei	City Area Code CityAreaCode	(833)
	dei	Local Phone Number LocalPhoneNumber	275-2266
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7821515	shares
CY2022Q3	us-gaap	Cash Cash	2656108	usd
CY2021Q4	us-gaap	Cash Cash	432530	usd
CY2022Q3	us-gaap	Restricted Cash RestrictedCash	10000	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	20000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	25499	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6280	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	188314	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	273394	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	2879921	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	732204	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4035	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12636	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1217206	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1144625	usd
CY2022Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	1221241	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1157261	usd
CY2022Q3	us-gaap	Assets Assets	4101162	usd
CY2021Q4	us-gaap	Assets Assets	1889465	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	718278	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1065304	usd
CY2022Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	450148	usd
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	696582	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2000000	usd
CY2022Q3	us-gaap	Dividends Payable Current DividendsPayableCurrent	0	usd
CY2021Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	3856898	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1168426	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7618784	usd
CY2022Q3	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	0	usd
CY2021Q4	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	7102229	usd
CY2022Q3	ACON	Redeemable Preferred Stock Value RedeemablePreferredStockValue	0	usd
CY2021Q4	ACON	Redeemable Preferred Stock Value RedeemablePreferredStockValue	7102287	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7821515	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7821515	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	905685	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	905685	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	78	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	9	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	41510853	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19054234	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38578195	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-31886036	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	2932736	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-12831606	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4101162	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1889465	usd
CY2022Q3	us-gaap	Revenues Revenues	18222	usd
CY2021Q3	us-gaap	Revenues Revenues	10865	usd
	us-gaap	Revenues Revenues	37924	usd
	us-gaap	Revenues Revenues	48315	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	17028	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	16086	usd
	us-gaap	Cost Of Revenue CostOfRevenue	48009	usd
	us-gaap	Cost Of Revenue CostOfRevenue	52954	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	1194	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	-5221	usd
	us-gaap	Gross Profit GrossProfit	-10085	usd
	us-gaap	Gross Profit GrossProfit	-4639	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	159388	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	78377	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	353456	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	209206	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	290966	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	275284	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	848995	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	605749	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1184100	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	438373	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3559225	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1064826	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	1634454	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	792034	usd
	us-gaap	Operating Expenses OperatingExpenses	4761676	usd
	us-gaap	Operating Expenses OperatingExpenses	1879781	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1633260	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-797255	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4771761	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1884420	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	128320	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	373511	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	2070	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	167626	usd
	us-gaap	Interest Expense InterestExpense	1505477	usd
	us-gaap	Interest Expense InterestExpense	307668	usd
CY2022Q3	ACON	Changes In Fair Value Of Redeemable Preferred Stock ChangesInFairValueOfRedeemablePreferredStock	0	usd
CY2021Q3	ACON	Changes In Fair Value Of Redeemable Preferred Stock ChangesInFairValueOfRedeemablePreferredStock	-2122234	usd
	ACON	Changes In Fair Value Of Redeemable Preferred Stock ChangesInFairValueOfRedeemablePreferredStock	0	usd
	ACON	Changes In Fair Value Of Redeemable Preferred Stock ChangesInFairValueOfRedeemablePreferredStock	-2122234	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2297	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6377	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	602	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4692	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	227	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2155163	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1504875	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2051699	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-1633033	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-2952418	usd
	us-gaap	Profit Loss ProfitLoss	-6276636	usd
	us-gaap	Profit Loss ProfitLoss	-3936119	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1633033	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2952418	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6276636	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3936119	usd
CY2022Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	-0	usd
CY2021Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	290735	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	415523	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	716573	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1633033	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3243153	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6692159	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4652692	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.58
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.58
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.21
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.21
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.14
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7821515	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7821515	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	905685	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	905685	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5516238	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5516238	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	905685	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	905685	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-7083601	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	30393	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	716573	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	93476	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3936119	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-11612424	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-12831606	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1280	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1050826	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6276636	usd
	ACON	Exercise Of Convertible Note Warrants Value ExerciseOfConvertibleNoteWarrantsValue	152653	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3856898	usd
	ACON	Conversion Of Preferred Stock To Common Stock Value ConversionOfPreferredStockToCommonStockValue	7102287	usd
	ACON	Conversion Of Accrued Interest On Promissory Notes Value ConversionOfAccruedInterestOnPromissoryNotesValue	1855158	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	8021876	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	125000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	814500	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	2932736	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6276636	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3936119	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	141852	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	139847	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1050826	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	93476	usd
	ACON	Warrants Issued As Noncash Finance Charge WarrantsIssuedAsNoncashFinanceCharge	0	usd
	ACON	Warrants Issued As Noncash Finance Charge WarrantsIssuedAsNoncashFinanceCharge	30393	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	373511	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3789	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-0	usd
	ACON	Changes In Fair Value Of Redeemable Preferred Stock ChangesInFairValueOfRedeemablePreferredStock	-0	usd
	ACON	Changes In Fair Value Of Redeemable Preferred Stock ChangesInFairValueOfRedeemablePreferredStock	-2122234	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19220	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-11824	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-85081	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	92710	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-347026	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	157830	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	981504	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	164642	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	200712	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	114404	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4179118	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1567690	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	160622	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	84984	usd
	us-gaap	Proceeds From Sale Of Furniture And Fixtures ProceedsFromSaleOfFurnitureAndFixtures	1000	usd
	us-gaap	Proceeds From Sale Of Furniture And Fixtures ProceedsFromSaleOfFurnitureAndFixtures	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-159622	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-84984	usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-2000000	usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	2000000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	8552318	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6552318	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2939500	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2213578	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1286826	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	452530	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14984	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2666108	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1301810	usd
	ACON	Dividends Accrued On Preferred Shares DividendsAccruedOnPreferredShares	415523	usd
	ACON	Dividends Accrued On Preferred Shares DividendsAccruedOnPreferredShares	716573	usd
	ACON	Exercise Of Convertible Note Warrants ExerciseOfConvertibleNoteWarrants	262171	usd
	ACON	Exercise Of Convertible Note Warrants ExerciseOfConvertibleNoteWarrants	0	usd
	ACON	Conversion Of Preferred Stock To Common Stock ConversionOfPreferredStockToCommonStock	25754379	usd
	ACON	Conversion Of Preferred Stock To Common Stock ConversionOfPreferredStockToCommonStock	0	usd
	ACON	Conversion Of Preferred Stock Dividends To Common Stock ConversionOfPreferredStockDividendsToCommonStock	4272420	usd
	ACON	Conversion Of Preferred Stock Dividends To Common Stock ConversionOfPreferredStockDividendsToCommonStock	0	usd
	ACON	Conversion Of Accrued Interest On Promissory Notes To Common Stock And Warrants ConversionOfAccruedInterestOnPromissoryNotesToCommonStockAndWarrants	1856438	usd
	ACON	Conversion Of Accrued Interest On Promissory Notes To Common Stock And Warrants ConversionOfAccruedInterestOnPromissoryNotesToCommonStockAndWarrants	0	usd
	ACON	Issuance Of Underwriters Warrants Related To Ipo IssuanceOfUnderwritersWarrantsRelatedToIpo	74677	usd
	ACON	Issuance Of Underwriters Warrants Related To Ipo IssuanceOfUnderwritersWarrantsRelatedToIpo	0	usd
CY2022Q2	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-7.47 reverse stock split
CY2022Q2	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-7.47 reverse stock split
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zhxGInuZAnt8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The financial statements include some amounts that are based on management's best estimates and judgments. The most significant estimates relate to depreciation, amortization, and valuation of capital stock and warrants and options to purchase shares of the Company's preferred and common stock. These estimates may be adjusted as more current information becomes available, and any adjustment could be significant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	2416000	usd
CY2021Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	201000	usd
CY2022Q3	us-gaap	Restricted Cash RestrictedCash	10000	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	1500000	usd
CY2022Q3	us-gaap	Deferred Offering Costs DeferredOfferingCosts	0	usd
	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	25140	usd
CY2022Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	450148	usd
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	340363	usd
CY2022Q3	us-gaap	Interest Payable Current InterestPayableCurrent	0	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	356219	usd
CY2022Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	450148	usd
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	696582	usd
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	1366	usd
CY2021Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	16933	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	33876	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	48697	usd
	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	26340	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	905685	shares
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2304497	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2093875	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1087292	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	949250	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1217206	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1144625	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	33958	usd
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	33387	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100541	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	94762	usd
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2489750	shares
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1633033	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3243153	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6692159	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4652692	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7821515	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7821515	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	905685	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	905685	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5516238	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5516238	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	905685	shares
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5617143	shares
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3562379	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5588823	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3131860	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2255672	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.84
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y2M12D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	529619	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	50201	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2735090	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.91
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y7M6D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	592532	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.58
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	215641	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2101708	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.86
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	326199	usd
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	84012	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1050826	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	93476	usd
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	615973	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P8Y7M6D

Files In Submission

Name	View Source	Status
0001683168-22-007614-index-headers.html	Edgar Link	pending
0001683168-22-007614-index.html	Edgar Link	pending
0001683168-22-007614.txt	Edgar Link	pending
0001683168-22-007614-xbrl.zip	Edgar Link	pending
aclarion_ex3101.htm	Edgar Link	pending
aclarion_ex3102.htm	Edgar Link	pending
aclarion_ex3201.htm	Edgar Link	pending
aclarion_ex3202.htm	Edgar Link	pending
aclarion_i10q-093022.htm	Edgar Link	pending
acon-20220930.xsd	Edgar Link	pending
acon-20220930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
acon-20220930_def.xml	Edgar Link	unprocessable
acon-20220930_lab.xml	Edgar Link	unprocessable
aclarion_i10q-093022_htm.xml	Edgar Link	completed
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
acon-20220930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACON
Aclarion, Inc. Stock $acon

2022 Q4 Form 10-Q Financial Statement

#000168316822007614 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACON Aclarion, Inc. Stock $acon

2022 Q4 Form 10-Q Financial Statement

#000168316822007614 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACON
Aclarion, Inc. Stock $acon